10:41 IST
BSE
Credit Rating
Trident Texofab Credit Rating
CRISIL Ratings has withdrawn the credit rating for Trident Texofab Ltd. This action follows a recent review of the company's financial and operational standing.
Trident Texofab Ltd
- Share price
- ₹21.50
- Market cap
- ₹32.24 Cr
- Revenue (annual)
- ₹118.0 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 153.2×Sector 55.7×
- Promoter holding
- 32.16%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Buying 2Financial Results 2Credit Rating 2Other Announcement 1Board Meeting Outcome 1Annual General Meeting 1
Time
2 announcements with these filters
10:39 IST
BSE
Credit Rating
Trident Texofab Credit Rating
Trident Texofab Limited has voluntarily withdrawn its credit ratings from CRISIL for bank facilities totaling Rs. 20 Crore. The ratings were reaffirmed at CRISIL B/Stable before withdrawal.
- Value
- ₹20.00 Cr